XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)
3 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended 18 Months Ended 26 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2010
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2011
Dec. 31, 2011
Sep. 30, 2012
Income Statement [Abstract]                
REVENUE:                        
OPERATING EXPENSES:                
Research and development 90,880 109,976 73,559 138,152 353,376 362,850 436,409 574,561
Selling, general and administrative 638,981 397,817 764,598 1,584,377 1,071,111 1,713,895 2,478,493 4,062,870
Depreciation 1,120 813    3,360 1,077 2,197 2,197 5,557
Total operating expenses 730,981 508,606 838,157 1,725,889 1,425,564 2,078,942 2,917,099 4,642,988
Loss from operations (730,981) (508,606) (838,157) (1,725,889) (1,425,564) (2,078,942) (2,917,099) (4,642,988)
Other income (expense):                
Interest expense (123,460) (48,043)    (542,497) (48,043) (182,929) (182,929) (725,426)
Loss on modification of debt                (88,849) (88,849) (88,849)
Loss on settlement of debt (829,530)       (829,530)    89,241 89,241 (829,530)
Gain/ Loss on change in fair value of derivative liabilities (450,330) (23,191)   (387,185) (23,191)     (297,944)
Loss before provision for income taxes (2,134,301) (579,840) (838,157) (3,485,101) (1,496,798) (2,261,479) (3,099,636) (6,584,737)
Provision for income taxes (benefit)                     
NET LOSS $ (2,134,301) $ (579,840) $ (838,157) $ (3,485,101) $ (1,496,798) $ (2,261,479) $ (3,099,636) $ (6,584,737)
Net loss per common share, basic and fully diluted $ (0.01) $ 0.00 $ (0.04) $ (0.02) $ (0.01) $ (0.01)    
Weighted average number of common shares outstanding, basic and fully diluted 255,221,874 339,017,691 20,955,199 235,323,859 237,157,904 226,844,313